Collegium to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Collegium Pharmaceutical (Nasdaq: COLL) has announced its upcoming participation in three major healthcare investor conferences in March 2025. The company's management will engage in investor meetings at the Leerink Partners 2025 Global Healthcare Conference on March 11, the Jefferies Biotech on the Beach Summit on March 12, and the Barclays 27th Annual Global Healthcare Conference on March 13.

News Market Reaction

-1.41%

1 alert

-1.41% News Effect

On the day this news was published, COLL declined 1.41%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

STOUGHTON, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that management will participate in investor meetings at the following investor conferences:

Leerink Partners 2025 Global Healthcare Conference
Tuesday, March 11, 2025

Jefferies Biotech on the Beach Summit
Wednesday, March 12, 2025

Barclays 27^th Annual Global Healthcare Conference
Thursday, March 13, 2025

About Collegium Pharmaceutical, Inc.
Collegium is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a leading portfolio of responsible pain management medications and recently acquired Jornay PM^®, a treatment for ADHD, establishing a presence in neuropsychiatry. Collegium’s strategy includes growing its commercial portfolio, with Jornay PM as the lead growth driver, and deploying capital in a disciplined manner. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

Investor Contacts:
Ian Karp
Head of Investor Relations
ir@collegiumpharma.com

Danielle Jesse
Director, Investor Relations
ir@collegiumpharma.com

Media Contact:
Cheryl Wheeler
Head of Corporate Communications
communications@collegiumpharma.com

FAQ

Which investor conferences will Collegium Pharmaceutical (COLL) attend in March 2025?

Collegium will attend three conferences: Leerink Partners Global Healthcare Conference (March 11), Jefferies Biotech on the Beach Summit (March 12), and Barclays Global Healthcare Conference (March 13).

When is Collegium Pharmaceutical (COLL) presenting at the Leerink Partners 2025 Conference?

Collegium management will participate in investor meetings at the Leerink Partners Global Healthcare Conference on Tuesday, March 11, 2025.

What is the schedule for COLL's participation in the Barclays Healthcare Conference 2025?

Collegium will participate in the Barclays 27th Annual Global Healthcare Conference on Thursday, March 13, 2025.

Is Collegium (COLL) participating in the Jefferies Biotech on the Beach Summit 2025?

Yes, Collegium management will participate in investor meetings at the Jefferies Biotech on the Beach Summit on Wednesday, March 12, 2025.